ANGECON
company
About
ANGECON focuses on the R&D of cell drugs, healthy cell storage and other fields.
- 11 - 50
Details
- Last Funding Type
- Angel
- Last Funding Money Raised
- ¥10M
- Industries
- Biotechnology,Health Care,Sales
- Founded date
- Feb 2, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥11.18M
ANGECON has raised a total of
¥11.18M
in funding over 2 rounds. Their latest funding was raised on
Sep 3, 2012 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 3, 2012 | Series A | ¥1.18M | 1 |
|
— | Detail |
| May 10, 2012 | Angel | ¥10M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
ANGECON is funded by 2 investors.
Fudewu Sheng
and Sanjie Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
Yes | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
